Pazufloxacin 注射液の投与量増加のための臨床第I 相試験.pdfPazufloxacin 注射液の投与量増加のための臨床第I 相試験.pdf

收藏 分享

资源预览需要最新版本的Flash Player支持。
您尚未安装或版本过低,建议您

ŠOQV415JŸš1BVGMPYBDJOWD”CWHŠWŸšHGF˜JG›0F›JRDRDG1BVGMPYBDJO1;9WD”CWHŠWŸšHG›H{BS˜J|ƒ1;9ANPHR›0TNHS‘|NHOSDS’|TNHSC033|SD|„ANPHR›0TNHSC033|SD|ANP›0TNHSC033|SDWˆ6S‘|†Q›U|H{DMOXMC•‹IQH{}ˆ6ANPWNH|NHS‘|NHOSDP|NBYQD”QWTQUˆ’•HU|6PXQXˆ’•STLH{ANPWNHIWD‰W6X|HRPXHISC033N|PXHISC033NPKLH{WDSWX6›GVXB”QQ’•H{‡H|NHSC033SDWBZSXHRS‘|MC•‹D‰LTX6TA|DPWUQXˆ’•STLH{}†QANT‘”NHOSDPWMS‘|WSR|NHOSDPWT‘”›‰WMS‘|WSRWUCQH{NHSDPWS‘|‘T‘”|WT‘”|S’|TWTW›‰’TWUCQHHŠD›H{OžSXˆ’•STLHU|U•HHŠHRQ‰SPK”ANT|™XU|B”\QQH{ANT‘”NHSDPHRPXT‘”›‰ET|Ÿ|WS‘|4ŸWUCQ|PXBT‘”›‰ETB|Ÿ|IS‘|SI|‘|M|WS‘|FOQWUCQHU|MC•‹0S‡HXSSPŸšGVSJQS”XCQSTLH{Ž‘“|ANWNHSC033|SDWHRS‘|W†QU•H{KEYWORDSQBVGMPYBDJO|IJHIEPTF|QIBSNBDPLJOFUJDT|N1QS‘|››QSWCUˆ’•|NFUIJDJMMJOSFTJTUBOUSTAPHYLOCOCCUSAUREUS34NFUIJDJMMJOSFTJTUBOUSTAPHYLOCOCCUSEPIDERMIDIS34SRWΒ•T0B”1QWˆS’C|QPXΒ•”ˆ\T‘”1Q˜|K”MXFYUFOEFETQFDUSVNΒ•”4ˆ\T‘”1QISR|Β•T0B”1QWT‘“|OQW›WCUˆ’•OM”™{FWHŠ|›TOQW›T0O|Β•Q;;WŸS”NW‰CUL‡•OMH{Ž1;9JHX|;”QODT•|DTXT0B”›CH{1;9XZUJ|{J|ŽJˆJSRWQPX–;•QS‘|†QU•OS“|;Β•SRPGSLU˜’•SM|,›B”OQ›SRT‹–;•OM”{T|NHSC033D‰CPX|BSRWOQ›S‘|OQF˜NSO•70/01BVGMPYBDJOWD”CWHŠWHGFIG1CHEMICALSTRUCTUREOFPAZUFLOXACINMESILATENCOOHCH3OOFH2NHCH3SO3HTABLE1SUBJECTSSUMMARIESFORPOPULATIONPHARMACOKINETICANALYSISHIGHMULTIPLEDOSEINELDERLYHIGHMULTIPLEDOSEINNONELDERLYHIGHSINGLEANDMULTIPLEDOSESINNONELDERLYCLASSIFICATIONMULTIPLEMULTIPLEMULTIPLESINGLE1,0001,0001,0002,0001,500DOSEMG108777N6973523337226322433622133MEANSDAGEYR695220210220200MEDIAN65,7520,3020,2921,3120,27MIN,MAX165550169942169963169444173432MEANSDHEIGHTCM16511695172316851734MEDIAN1599,17501631,17681574,17541647,17591689,1794MIN,MAX6126861471628885976264778MEANSDWEIGHTKG587597613573648MEDIAN524,700530,725534,766525,706546,792MIN,MAX2232321217217222092521419MEANSDBMIKG/M2223215216202217MEDIAN191,261191,237195,249184,248191,246MIN,MAX10411951176172147431712491871384204MEANSDCCRML/MIN10271149157012601360MEDIAN75,139102,154105,18399,144106,174MIN,MAXWJQS“O”WW˜TXMHLOS’C|\•’WOQ›T0B‚X|‘“SL›˜”HŠWMFU{Š’•OMH{1,1WT’WLX›T6C033Q‘S›B\QUŒ’•OS“|D”WCXQ›Š”QQ’•OM”{ŠNXCŽR|OQ››‰T–;•|†QU•OM”{ŠOQT’X|ŠNXOQ›T0O‹0PV”NQ”NZ”QWQT’|†QUPV”C“PB›ŠHOQ›T0|‘“SQ›84B‚X|;”›–;PV”‘OTQWAL{UDT\‡G|TZ•H{F\P|OQ›T0O‹|’TTL›˜”HŠTD”C|BS˜J|NHSC033DW;O;”›CB”\Q›HH{\•‡PT|1;9NHSC033DPXŠNT›WOGS;XCQOS’C|†QX•HQQOM”{\•’W\QT’|1;9WD”CWHŠWŸšHG›|ˆ6S‘|†Q›U|H{SS|ŠGXƒWG•Q3W›˜”QQ‹T|WŸšGWW,J1RD\H›OO•H{I}0QMO}GƒANPW;”OSS‘|SGXTP|ANPW;”SGS‘|;”SGX;FPH{}ƒGŠGWTŒQJ|ƒGT1PŠ”0TMMOGT†|™T‘”G€CW‰™›ŠT’{P˜H{FW™|UPŠGTPK”QQ•HƒG›0QH{}G|D”|DMOS‘|D8G1;9ANX|NT1;9QONHŽNHB”›;MH{ANX|NT1;9QONHŽNHB”N›;MH{D”|DMOS‘|D8ANPW;”OSS‘|SGHR›0TIPWNHOSDX|NHOSDX|NHSC033|SDXPH{ANPW;”SGHR›0TIPWNHSC033|SDX1;9|PH{SS|D‰S‘|DXŠOQV415TABLE2SCHEDULEOFSINGLEDOSESTUDYFOLLOWUP8121-1SCREENINGDAY-28TO-2TIME●●INFORMEDCONSENT●●SUBJECTBACKGROUND●HOSPITALIZATION●DRUGADMINISTRATION●●●●●INVESTIGATOREXAMINATION●●●●●VITALSIGNSBLOODPRESSURE,PULSERATE,RESPIRATORY,TEMPERATURE●●●●●12LEADELECTROCARDIOGRAM●IMMUNOLOGICALTESTCLINICALLABORATORYTEST●●●●HEMATOLOGY,BLOODBIOCHEMISTRY,URINALYSIS●●SERUMPHARMACOKINETICMONITORING●●URINE●CRYSTALLURIA滑害害害害害害害害害害害害害害葛ADVERSEEVENTS●DISCHARGE24HR12HR11HR8HR6HR4HR3HR2HR90MIN75MIN65MIN60MIN30MIN0MIN-60MINDRUGADMINISTRATION●●●●INVESTIGATOREXAMINATION●●●●12LEADELECTROCARDIOGRAM●CLINICALLABORATORYTEST●●●●VITALSIGNSBLOODPRESSURE,PULSERATE,RESPIRATORY,TEMPERATURE●●●●●●●●●●●●●SERUMPHARMACOKINETICMONITORINGURINECRYSTALLURIA滑害害害害害葛滑害害葛滑害害害害害害害害害害害害害害害害葛滑害害害害害葛滑害害葛滑害害葛滑害害害害害葛滑害害葛滑害害葛滑害害害害害害害害害害害害害害害害葛滑害害害害害葛滑害害葛滑害害葛S|D™XSDQH{ANPW;”SG›0TIPWNHSC033|SDX1;9|PH{SS|D‰S‘|DXS|D™XSDQH{HGQWD”|ƒG|||O|PEZNBTTJOEFYS‘|DS›5BCMFTH{}S‘|8ANPW;”OSS‘|SG|ANPW;”SGS‘|;”SGWUS’|TOSRW”›5BCMFS‘|5BCMFTH{ƒG›QWGD‰TQ|\D|O|7|ž”7|,S‘|FWOS|WG€CW|GDŽWN;W|”UŽS‘|U™WBW|PWW›H{ŸšUS‘|OANPW;”OSS‘|SG|ANPW;”SGS‘|;”SGWUS’|TO›5BCMFTH{FW8TO||‹|ŸšUBU|B\U|U|BU|BYZUS‘|9S‘|AO›LH{SUWJANPW;”OSS‘|SGBWX|OSDPXD‰S‘|D‰™WPNQH5BCMF{SDPXDXD‰S‘|D‰™W|™XD‰S‘|D‰™W|TXD‰S‘|D‰™WPNQH5BCMF{70/01BVGMPYBDJOWD”CWHŠWHGTABLE3SCHEDULEOFMULTIPLEDOSESTUDYFOLLOWUP121A131B7B654321-1SCREENINGDAY-28TO-2TIME●●INFORMEDCONSENT●●SUBJECTBACKGROUND●HOSPITALIZATION●B●●●●●DRUGADMINISTRATION●●●●●●●●●●INVESTIGATOREXAMINATION●●●●●●●●●●VITALSIGNSBLOODPRESSURE,PULSERATE,RESPIRATORY,TEMPERATURE●●●●●●12LEADELECTROCARDIOGRAM●IMMUNOLOGICALTESTCLINICALLABORATORYTEST●●●A●●●HEMATOLOGY,BLOODBIOCHEMISTRY,URINALYSIS●●●●●●●SERUMPHARMACOKINETICMONITORING●●●●●●●URINE●●CRYSTALLURIA●DISCHARGE滑害害害害害害害害害害害害害害害害害害害害害害葛ADVERSEEVENTSAHIGHMULTIPLEDOSEINNONELDERLYWITH1PZFXBHIGHMULTIPLEDOSEINNONELDERLYANDELDERLYWITH05PZFXCONTINUEDWX|OSDPXD‰™|D‰™™|™|™|™|™|™|SDPXD‰XD‰™|D‰™™|™|™|™|™|™T|D™XD‰™™|™|™T|DXD‰™™|™|™|™|™|™TNQH5BCMFS‘|5BCMF{JJANPW;”SGS‘|;”SGBWX|DXD‰|D‰™W|D™XD‰|D‰™W|DTXD‰|D‰™WPNQH5BCMF{WX|D‰XD‰|D‰™™|™|™|™|™|™T|D™XD‰™™|™|™T|DXD‰™™|™|™|™|™|™TNQH5BCMF{MOHBXMSQN||OBZ›M|ŽTZAH{‡H|HXŽTZAH{1;9WWBZS‘|S›QPŸ”1OT‘“H{WŠGQWLTTT˜’C|GD‰T’™U‡PTGUD•HƒGT\AHB‚OW‡XSM|‡HX™SMS‘|ŸšU‹WŸˆ|WŸšTJQS”ŸWCQ|‡HX›QH{Ÿ‹T’,J‹NXˆXŸˆQSTLH{‡H|W™U’TTS”‡P{›LH{TMMOX|ƒGWJ||;|;O|NDQCQQWSRT’GQWL›’TTK“|K“|K”T‹•SMS‘|SWˆŠPQH{GQWLU|’TTK“|K“‡HXK”T‹•SMQQ•H‹W›;QO“{LH{‡H|WSXT‘”GTSZ”;|ŸšU‹ŸWQ,J›€T0S|SS‡HXOSWˆŠPQH{SS|XM;BŠFE3C033WFST,NV,Š1SFGFSSFE5FSN€15Tˆ8Q|CQS›BH{}RSˆ6RSˆ6”T‘SMRSO›;MO|NBY|6|7ŠOQV415TABLE3CONTINUEDDAY2424HR13HR12
编号:201312191513517195    类型:共享资源    大小:879.74KB    格式:PDF    上传时间:2013-12-19
  
5
关 键 词:
管理 组织 经营
  人人文库网所有资源均是用户自行上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作他用。
关于本文
本文标题:Pazufloxacin 注射液の投与量増加のための臨床第I 相試験.pdf
链接地址:http://www.renrendoc.com/p-247195.html

当前资源信息

4.0
 
(2人评价)
浏览:10次
abaodong上传于2013-12-19

官方联系方式

客服手机:17625900360   
2:不支持迅雷下载,请使用浏览器下载   
3:不支持QQ浏览器下载,请用其他浏览器   
4:下载后的文档和图纸-无水印   
5:文档经过压缩,下载后原文更清晰   

相关搜索

精品推荐

相关阅读

人人文库
关于我们 - 网站声明 - 网站地图 - 资源地图 - 友情链接 - 网站客服客服 - 联系我们

网站客服QQ:2846424093    人人文库上传用户QQ群:460291265   

[email protected] 2016-2018  renrendoc.com 网站版权所有   南天在线技术支持

经营许可证编号:苏ICP备12009002号-5